Lessons learned through the intensive development of the Covid-19 vaccine could help in the development of a cancer vaccine. The founders of coronavirus jab manufacturers BioNTech say they could have a cancer jab by 2030.
In an amazing feat of scientific advancement, BioNTech co-founders and professors Ugur Sahin and Ozlem Tureci say the Covid pandemic sped up the use of mRNA technology in real life.
The husband and wife team, which co-founded its company in Mainz, Germany, in 2008, has been working on pioneering and tailored cancer immunotherapies. Conventional vaccines use weakened forms of a virus whereas mRNA only uses a virus' genetic code, reports The Express.
